Glenn Coleman - 29 May 2026 Form 4 Insider Report for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)

Reporting relationship: EVP & Chief Financial Officer
Issuer ticker: CRL
Reported as of: 29 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Jun 2026, 16:46:05 UTC
Prior SEC filing: 04 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Glenn Coleman

Key filing fact

Glenn Coleman filed Form 4 for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) on 02 Jun 2026.

Key facts

This page summarizes Glenn Coleman's Form 4 filing for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Jun 2026, 16:46.

Change

Previous filing in this sequence was filed on 04 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001434369 Primary reporting owner

Coleman Glenn

Relationship: EVP & Chief Financial Officer
Address: C/O CHARLES RIVER LABORATORIES, 251 BALLARDVALE ST, WILMINGTON
Signature: /s/ Glenn Coleman
Signature date: 02 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRL transaction

Common Stock

Award

Transaction value
Shares: +6,640
Change %: +31%
Price: $180.71^*
Shares after: 27,752
Date: 29 May 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Unvested restricted stock units annually ratably vest on May 29, 2027; May 29, 2028; May 29, 2029; and May 29, 2030.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .